San Jose, Calif., Jan. 9, 2013 – Ariosa Diagnostics is pleased to announce that they have entered into a mutual partnership with The Doctors Laboratory, in London, to promote and distribute the Harmony Prenatal Test. Under the terms of the agreement, TDL will offer the Harmony test through their reference laboratory services to doctors and their pregnant patients.
Ken Song, M.D., CEO of Ariosa Diagnostics, said, “We are pleased to have partnered with TDL Genetics to offer the Harmony test. The quality of service that TDL offers aligns with our goal to responsibly introduce our test in markets outside of North America.”
Dr. Lisa Levett, director of TDL Genetics, said: “Non-invasive prenatal testing is one of the most exciting and important developments in this field in the last 50 years. Our laboratory has always been at the forefront of the latest prenatal diagnostic technology – for example, we developed the first rapid PCR- based prenatal Down syndrome test, Amnio-PCR or qf-PCR. We are delighted to be working with Ariosa to bring the non-invasive HarmonyTM Prenatal Test to the many doctors and hospitals we work with in the UK and overseas.”
About The Doctors Laboratory
The Doctors Laboratory (TDL) is the largest independent clinical pathology organisation in the UK, providing a multidisciplinary range of testing services to both the NHS and Independent Healthcare sectors. TDL's laboratories are CPA accredited in all disciplines. Its main laboratory is based in central London, with smaller laboratories strategically positioned throughout the UK. These laboratories provide pathology services to hospitals, laboratories and clinical practice, and are supported by their own distribution and logistics network. For more information, visit www.tdlpathology.com.